The 63 references in paper N. Savenkova D., Н. Савенкова Д. (2013) “СТРАТЕГИЯ ТЕРАПИИ ДЕБЮТА, РЕЦИДИВИРУЮЩЕГО И ЧАСТО РЕЦИДИВИРУЮЩЕГО ГОРМОНОЧУВСТВИТЕЛЬНОГО И ГОРМОНОЗАВИСИМОГО НЕФРОТИЧЕСКОГО СИНДРОМА С МИНИМАЛЬНЫМИ ИЗМЕНЕНИЯМИ У ДЕТЕЙ // TREATMENT STRATEGY FOR INITIAL OF RELAPSING AND FREQUENT RELAPSING STEROID SENSITIVE AND STEROID DEPENDENT MINIMAL CHANGE NEPHROTIC SYNDROME IN CHILDREN” / spz:neicon:nefr:y:2013:i:3:p:17-25

1
Международная статистическая классификация болезней и проблем, связанных со здоровьем (Х пересмотр ВОЗ, 1995, Женева). Класс XIV. Раздел болезней мочеполовой системы (N00-N99)
(check this in PDF content)
2
International study of kidney disease in children. Nephrotic syndrome in children: prediction of hystopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978;13:159–163
(check this in PDF content)
3
International study of kidney disease in children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. А Report of the International Study of Kidney Disease in Children. J Pediatr 1981; 98: 561–564
(check this in PDF content)
4
Churg J, Sobin LH. Renal disease (classification and atlas of glomerular disease). Igaku-Shoin, Tokyo-New York, 1982; 359
(check this in PDF content)
5
Fogo A. Renal Pathology. In Pediatric Nephrology. Senior Editor E. Avner. IPNA. Springer-Verlag 2009; Vol 1: 565-598
(check this in PDF content)
6
Pavenstadt H, Kriz W. and Kretzler M. Cell Biology of Glomerular Podocyte. Physol Rev 2003;15:253-307
(check this in PDF content)
7
Patrakka J, Jahdenkari, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H. The number of podocite slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr res 2002; 52:349-355
(check this in PDF content)
8
Gbadegesin R. and Smoyer W. Nephrotic Syndrome. Comprehensive Pediatric Nephrology. Editors D.Geary, F. Schaefer. MOSBY 2008; 205-218
(check this in PDF content)
9
Hodson E, Alecsander S, and Graf N. Steroid-Sensitive Nephrotic Syndrome/ In Comprehensive Pediatric Nephrology. Editors D.Geary, F. Schaefer. MOSBY 2008; 239-256
(check this in PDF content)
10
Niauted P. Steroid-Sensitive Idiopatic Nephrotic Syndrome in Children. In Pediatric Nephrology. Editors E.Avner, W.Harmon, P.Niauted. LIPPINCOTT-WILLIAMS-WILKINS, 2004: 544-556
(check this in PDF content)
11
Niauted P, Boyer O. Idiopathic Nephrotic Syndrome in Children: Clinical Aspects. In Pediatric Nephrology, 6- th edition. Editors E. Avner, W.Harmon, N Yoshikawa. IPNA. Springer-Verlag, 2009; 1:667-702
(check this in PDF content)
12
Савенкова НД, Папаян АВ. Нефротический синдром в практике педиатра. Эскулап, СПб., 1999; 256
(check this in PDF content)
13
Игнатова МС, Шатохина ОВ. Диагностика и лечение нефротического синдрома у детей. Руководство для врачей. М: ООО «Медицинское информационное агенство», 2009; 300
(check this in PDF content)
14
Савенкова НД, Папаян АВ, Батракова ИВ. Нефротический синдром с минимальными изменениями у детей. Папаян А.В., Савенкова Н.Д. Клиническая нефрология детского возраста. Левша.Санкт-Петербург, СПб., 2008; 279-302
(check this in PDF content)
15
Цыгин АН. Нефротический синдром. Детская нефрология. Под ред Э. Лоймана, А.Н.Цыгина, А.А.Саркисяна. Литтерра, М., 2010; 123-140
(check this in PDF content)
16
Cambon-Thomsen A, Bouisson F, Abbal M et al. HLA and B12 in idiopathic nephrotic syndrome of children. Differences between steroid sensitive and steroid resistant patients. Pathol Biol 1986; 34: 725-730
(check this in PDF content)
17
Konrad M, Mytilineos J, Ruder H, Opelz G et al: HLA-DR 7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 1997; 11:16-19
(check this in PDF content)
18
Папаян АВ, Серга АП. Иммунопатология нефротического синдрома при гломерулонефрите с минимальными изменениями (липоидный нефроз). Педиатрия 1985; 11: 66-69
(check this in PDF content)
19
Батракова ИВ, Савенкова НД. Особенности течения нефротического синдрома с минимальными изменениями у детей с повышением специфических IgE. Матералы Х съезда педиатров России. Москва, 8-10 февраля, 2005. Вопросы современной педиатрии. 2005; 4:23
(check this in PDF content)
20
Shimada M, Araya C, Rivald C et al. Minimal change disease: a «two-hit» podocyte immune disorder? Pediatr Nephrol 2011;26:645-649
(check this in PDF content)
21
Tain YL, Chen TY, Yang KD. Implication of serum Ig E in childhood nephritic syndrome. Pediatr Nephrol 2003; 18 (12): 1211-1221
(check this in PDF content)
22
Тур ИИ, Савенкова НД, Назаров ПГ и др. Сравнительное исследование IgE-антител, IFNγ- и IL-4 у детей с нефротическим синдромом с минимальными изменениями и атопическим дерматитом. Нефрология 2007; 4:69-74
(check this in PDF content)
23
Arbeitsgemeinschaft fur Padiatrische Nephrologie Short versus standart prednisolone therapy for initial treatment of idiopatic nephrotic syndrome in children. Lancet 1988; 1: 380-383
(check this in PDF content)
24
Arbeitsgemeinschaft fur Padiatrische Neophrologie. Minimal change nephrotic syndrome: long prednisone versus standard prednisone therapy. Pediatr Nephrol 1990; 4: 60
(check this in PDF content)
25
Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children Clin Nephrol 1991; 35(1): 8-15
(check this in PDF content)
26
Ehrich JHH, Brodehl J. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Long versus standard prednisone therapy for initial of idiopathic nephrotic syndrome in children Eur J Pediatr 1993; 152: 357-361
(check this in PDF content)
27
Bargman JM. Management of minimal lesion glomerulonephritis Evidence-based recommendations. Kidney int 1999; 70 (55): 3-16
(check this in PDF content)
28
А Report of the International Study of Kidney Disease in Children. Early identification of frequent relapsers among children with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1982; 101:514-518
(check this in PDF content)
29
Lande MB, Leonard MB Variabiliy among pediatric nephrologists in the initial therapy of nephritic syndrome. Pediatr Nephrol 2000; 14: 766-769
(check this in PDF content)
30
Gipson DS, Massengill SF, Yao L et al. Management of childhood onset nephritic syndrome. Pediatrics 2009; 124: 747756
(check this in PDF content)
31
Teeninga N, Kist-Van Holthe JE, Van Rusvuk N et al. Effect of extended Prednisolone treatment from threetosix monts, with equal cumulative doses, on childchood nephritic syndrome: A national-wide randomized controlled trial. Abstracts. The 45th Annual Meeting of the ESPN, on September 6th-8th 2012, Krakow, Poland. Pediatr Nephrol 2012; 27:1637
(check this in PDF content)
32
Clark A, Barratt TM. Steroid-responsive nephrotic syndrome. Edited by Т.М. Barratt, E.D. Avner, WE Harman. Pediatric nephrology. LIPPINCOTT-WILLIAMS-WILKINS, 1998; 731-747
(check this in PDF content)
33
Andersen RF, Thragt N, Noergard K et al (2010) Early age at debut is a predictor of steroid-dependetn and frequent relapsing nephritic syndrome. Pediatr Nephrol 2010; 25: 1299-1304
(check this in PDF content)
34
Husen M, Kemper MJ. New therapies in steroidsensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 2011; 26: 881-892
(check this in PDF content)
35
Vester U, Kranz B. Cyclophosphamide in steroid-sensitive nephrotic syndrome outcome and outlook. Pediatr Nephrol 2003; 18: 661-664
(check this in PDF content)
36
Kemper J, Altrogge H, Ludwig K et al. Unfavorable response to cyclophosphamide in steroid-dependent nephritic syndrome. Pediatr Nephrol 2000;14: 772-775
(check this in PDF content)
37
Arbeitsgemeinschaft fur Padiatrische Nephrologie: Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Arch Dis Child 1987; 62: 1102-1106
(check this in PDF content)
38
Grup W, Makker SP, Ingelfinger JR: Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 1976; 295: 746-749
(check this in PDF content)
39
Azib S, Macher M, Kwon T et al. Cyclophosphamide in steroid dependent nephrotic syndrome. Pediatr Nephrol 2011; 26: 927-932
(check this in PDF content)
40
Zagury A, Louse A, de Ollveira et al. Long- term follow-up after cyclophosphamide therapy in steroid dependent nephrotic syndrome. Pediatr Nephrol 2011; 26: 915-920
(check this in PDF content)
41
Tejani A, Buttk,Trechtman H. Cyclosporin A induced remission of frequently relapsing nephrotic syndrome in children. Kidney Int1988; 33:729-734
(check this in PDF content)
42
Tanaka Н, Yoshikava N, Kitano Y. Long-term Cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1999; 7: 249-252
(check this in PDF content)
43
Батракова ИВ, Савенкова НД. Цитостатическая терапия нефротического синдрома с минимальными изменениями у детей. Нефрология 2004; 2:98-105
(check this in PDF content)
44
Rinaldi S, Sesto A, Barsotti P et al. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 2005; 20: 25-29
(check this in PDF content)
45
Игнатова МС, Турпитко ОЮ, Харина ЕА, Обухова ВА. Результаты многоцентрового изучения эффективности циклоспорина А при нефротическом синдроме у детей. Педиатрия 2008; 87:93-97
(check this in PDF content)
46
Matsumoto H, Hakao T, Okada T et al. Initial remission inducing effect of very low-olose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japannese adults. Clin Nephrol 2001; 55(2): 143-148
(check this in PDF content)
47
Wang W, Xia Y, Mao J et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic ntphrotic syndrome. Pediatr Nephrol 2012; 27: 2073-2079
(check this in PDF content)
48
Ulinski Т, Bruno Ranchin, Marie-Helene Said et al. Switch from cyclosporin A (Cy A) to mycophenolate mofetil improves kidney function in children with nephrotic syndrome and Cy Ainduced nephrotoxicity. Abstracts book from the World Congress of Nephrology June 8-12, 2003 Berlin. Nephrol Dial Transplant 2003; 18 (suppl 4): 261
(check this in PDF content)
49
Honda M. Nephrotic syndrome and mizoribine in children. Pediatrics International (2002) 44: 196-198
(check this in PDF content)
50
Fujinaga S, Hirano D, Nihizaki N et al. Single daily higt –dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporin administration. Pediatr Nephrol 2011; 26: 479-483
(check this in PDF content)
51
Novak L, Frank R, Vento S et al. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2005; 20(9) 1265-1268
(check this in PDF content)
52
Caropreso MR, Ferreti AV, Margieri G et al. Mycophenolate mofetil in the treatment of children with steroid-dependent nephrotic syndrome. Nephrol Dial Transplant 2003; 18(Suppl 4): 65
(check this in PDF content)
53
Hogg R, Fizgibbons L, Bruick J et al. Multicenter trial of mycophenolate mofetil (MMF) in children with steroid dependent (SD) or frequently relapsing (FR) nephrotic syndrome (NS). Report of the southwest pediatric nephrology study group. Abstract book from the World Congress of Nephrology. June 8-12, Berlin (2003). Nephrol Dial Transplan 2003; 18 (Suppl. 4): 261
(check this in PDF content)
54
Barletta GM, Smoyer WE, Bunchmann TE et al. Use of mycophenolate mofetil in steroid-dependent and-resistant nephrotic syndrome. Pediatr Nephrol 2003; 18:833-837
(check this in PDF content)
55
Vallejo GG, Liern MM, De Reyes VV et al. Enteric Coated Mycophenolate Sodium in Patients with steroid-dependent nephrotic syndrome. Congress Abstracts the 15th Congress of the International Pediatric Nephrology Association. August 29- September2, 2010, New York. Pediatr Nephrol 2010; 25:1886
(check this in PDF content)
56
Banerjee S, Pahari A, Sengupta J, Patnaik S. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol 2013; 28:93-97
(check this in PDF content)
57
Tendron A, Gouyon J, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies Pediatr Nephro. 2002; 17(2): 121-130
(check this in PDF content)
58
Kemper MJ, Moeller C, Rink N, Van Husen M, MullerWiefel D. Treatment of Referactory Steroid Sensitive Nephrotic Syndrome (SSNS) with Rituximab. Abstracts the 14th Congress of the International Pediatric Nephrology Association. 31 August- 4 September 2007, Budapest, Hungary. Pediatr Nephrol 2007; 22:1445
(check this in PDF content)
59
Sellier-Leclere A-L, Macher M-A, Loirat C. et al. Rituximab in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2010; 25: 1109-1115
(check this in PDF content)
60
Fujinaga S, Hirano D, Nishizaki N et al. Single infusion of Rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long term cyclosporine. Pediatr Nephrol 2010; 25: 539-544
(check this in PDF content)
61
Prytula A, Iijima K, Kamei К et al. Rituximab in refractory nephrоtic syndrome. Pediatr Nephrol 2010; 25:461-468
(check this in PDF content)
62
Musielak A, Silska M, Lipkowska K et al. Rituximab as a non-standart immunosuppressive therapy in children with nephrotic syndrome – a single pediatric nephrology center experience. Abstracts the 44-th Annual Scientific Meeting of the European Society for Paediatric Nephrology. 14-17 September 2011, Cavtat–Dubrovnik. Pediatr Nephrol 2011; 26:1646
(check this in PDF content)
63
Haffner D, Fischer D. Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 2009; 24:1433-1438 Поступила в редакцию 08.04.2013 г. Принята в печать 05.06.2013 г.
(check this in PDF content)